Tardive dyskinesia can affect many areas of your life, including your social life and self-confidence. Learning how to manage these effects can help improve your overall well-being and daily ...

While medications can help manage symptoms, many people with tardive dyskinesia are interested in natural therapies as an alternative or complementary approach. What the Research Says About Non ...

Neurocrine Biosciences (Nasdaq: NBIX) has announced positive results from its Phase IV KINECT-PRO study, showing that ...

Tardive dyskinesia (TD) is a form of drug-induced (iatrogenic) movement disorder that is one form of tardive syndrome. Other forms of tardive syndrome include tardive stereotypy, tardive chorea, ...

Uncontrollable movements from tardive dyskinesia (TD) can put a strain on your daily life, physically and mentally. Developing a stress management routine, employing social strategies, and seeking ...

TD, or tardive dyskinesia, is pretty much uncontrollable, jerky movements of the body. Smacking of the lips, licking, or jaw movements. I have Tourette's, and I kind of feel like it's just an ...

Biosciences announced top-line data from a Phase 4 study, KINECT-PRO, demonstrating clinically meaningful and sustained ...

The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD. The condition is characterised by uncontrollable movement of the body or ...

Wedbush analyst Laura Chico lowered the firm’s price target on Neurocrine (NBIX) to $147 from $157 and keeps an Outperform rating on the ...